ライフサイエンスコーパス: polytetrafluoroethylene

1 e Fidelis, and 23% were coated with expanded polytetrafluoroethylene.

2 ase microextraction (SPME) coatings based on polytetrafluoroethylene amorphous fluoroplastics (PTFE A

3 In contrast, both polytetrafluoroethylene and a range of nanostructured su

4 repair has created a niche for both expanded polytetrafluoroethylene and composite mesh, as they are

5 ll attachment and spreading whereas cells on polytetrafluoroethylene and polylactic acid barriers exh

6 Porous polytetrafluoroethylene and polyurethane skirt materials

7 ferent barrier materials (collagen, expanded polytetrafluoroethylene, and polylactic acid).

8 However, polytetrafluoroethylene arteriovenous grafts are prone t

9 Six-millimeter polytetrafluoroethylene arteriovenous grafts were create

10 Polytetrafluoroethylene arteriovenous shunts were create

11 ent developments such as PVR with a man-made polytetrafluoroethylene bicuspid valve and percutaneous

12 erformed on 143 leads (80% thin, 7% expanded polytetrafluoroethylene coated), with lead age as the on

13 de degradation, whereas chemically resistant polytetrafluoroethylene coating materials offer higher p

14 A reinforced 6-mm polytetrafluoroethylene conduit was tunneled between bot

15 guided beating-heart MV repair with expanded polytetrafluoroethylene cordal insertion has the potenti

16 Multiple expanded polytetrafluoroethylene cords were anchored in the leafl

17 ion of extraction sockets using high-density polytetrafluoroethylene (dPTFE) membranes without the us

18 ntional balloon angioplasty with an expanded polytetrafluoroethylene endovascular stent graft for rev

19 lized freeze-dried bone allograft (DFDBA) to polytetrafluoroethylene (ePTFE) and DFDBA for the treatm

20 tudy was to evaluate the effects of expanded polytetrafluoroethylene (ePTFE) and polylactic acid (PLA

21 the periodontium, cells adherent to expanded polytetrafluoroethylene (ePTFE) augmentation membranes,

22 One socket was covered with an expanded polytetrafluoroethylene (ePTFE) barrier membrane (experi

23 bone replacement graft material or expanded polytetrafluoroethylene (ePTFE) barrier membrane was eva

24 Expanded polytetrafluoroethylene (ePTFE) barrier membranes have b

25 afted with DFDBA and augmented with expanded polytetrafluoroethylene (ePTFE) barrier membranes.

26 PLA) barrier or the non-resorbable, expanded polytetrafluoroethylene (ePTFE) barrier.

27 vice designed to implant artificial expanded polytetrafluoroethylene (ePTFE) cords on mitral leaflets

28 As a vascular conduit, expanded polytetrafluoroethylene (ePTFE) is susceptible to graft

29 absorbable collagen membrane and an expanded polytetrafluoroethylene (ePTFE) membrane (non-resorbable

30 ted by combination therapy using an expanded polytetrafluoroethylene (ePTFE) membrane and demineraliz

31 ograft membrane or a non-resorbable expanded polytetrafluoroethylene (ePTFE) membrane as a barrier in

32 freeze dried bone allograft and an expanded polytetrafluoroethylene (ePTFE) membrane were utilized t

33 esults to those following use of an expanded polytetrafluoroethylene (ePTFE) membrane.

34 ble success rates to non-absorbable expanded polytetrafluoroethylene (ePTFE) membranes and convention

35 cells to repopulate wounds by using expanded polytetrafluoroethylene (ePTFE) membranes to exclude gin

36 ided tissue regeneration (GTR) uses expanded polytetrafluoroethylene (ePTFE) membranes to favor the r

37 Expanded polytetrafluoroethylene (ePTFE) membranes were used to p

38 med in furcation defect sites using expanded polytetrafluoroethylene (ePTFE) membranes, while the oth

39 ted osseous defects with or without expanded polytetrafluoroethylene (ePTFE) membranes.

40 th premolars received nonresorbable expanded polytetrafluoroethylene (ePTFE) membranes.

41 ided tissue regeneration (GTR) with expanded polytetrafluoroethylene (ePTFE) non-resorbable barriers

42 cortical-ilium-strips (DUIS) and an expanded polytetrafluoroethylene (ePTFE) physical barrier in comb

43 ded tissue regeneration (GTR) using expanded polytetrafluoroethylene (ePTFE), GTR using a bioabsorbab

44 l debridement (DEBR) or COLL versus expanded polytetrafluoroethylene (ePTFE).

45 dried bone allograft [DFDBA] and an expanded polytetrafluoroethylene [ePTFE] membrane) to DFDBA and a

46 our different regenerative methods (expanded polytetrafluoroethylene [ePTFE] titanium reinforced memb

47 were covered with a non-resorbable (expanded polytetrafluoroethylene [ePTFE]) membrane to exclude sof

48 Silicone and polytetrafluoroethylene eyelid implants are important ad

49 mity triboelectrification of two surfaces: a polytetrafluoroethylene film coated with a two-column ar

50 s using a multichannel flow reactor, Teflon (polytetrafluoroethylene) film bag batch reactors, and ou

51 ndustry were studied in this work, including polytetrafluoroethylene filter membranes, PVC, cellulose

52 Participants undergoing hemodialysis with a polytetrafluoroethylene graft in the arm were randomized

53 nts covered with woven polyester or expanded polytetrafluoroethylene graft material and were deployed

54 and neointimal smooth muscle cells in baboon polytetrafluoroethylene grafts is regulated by blood flo

55 the effects of TIPS with stents covered with polytetrafluoroethylene in these patients.

56 ylene in 16 eyes and CV-8 Gore-Tex (expanded polytetrafluoroethylene) in 3 eyes.

57 production of fluorinated polymers including polytetrafluoroethylene, increases the incidence of live

58 l experience with a novel preformed expanded polytetrafluoroethylene knot implantation device (Harpoo

59 inless-steel covered with woven polyester or polytetrafluoroethylene material.

60 either DFDBA (canine source) and an expanded polytetrafluoroethylene membrane (ePTFE), ePTFE membrane

61 either DFDBA (canine source) and an expanded polytetrafluoroethylene membrane (ePTFE), ePTFE membrane

62 The microbial colonization of expanded polytetrafluoroethylene membrane by putative periodontop

63 Experimental sites received a polytetrafluoroethylene membrane following surgical expo

64 eze-dried bone and coverage with an expanded polytetrafluoroethylene membrane resulted in rapid and c

65 Coating a synthetic polytetrafluoroethylene membrane with multiple layers of

66 allograft covered by a non-resorbable dense polytetrafluoroethylene membrane.

67 s were covered with a nonresorbable expanded polytetrafluoroethylene membrane.

68 cal osseous defects with nonporous or porous polytetrafluoroethylene membranes in combination with a

69 to clinically evaluate the effectiveness of polytetrafluoroethylene membranes in the healing of inte

70 ggests that guided tissue regeneration using polytetrafluoroethylene membranes is of some but limited

71 Reinforced expanded polytetrafluoroethylene membranes were placed in the ani

72 pare the regenerative effects of a nonporous polytetrafluoroethylene (NP) periodontal membrane to a p

73 perpendicular to the linear hole in the thin polytetrafluoroethylene overwrap, which would be consist

74 P) periodontal membrane to a porous expanded polytetrafluoroethylene (P) periodontal membrane in the

75 e randomized into three groups: 135 PCs, 135 polytetrafluoroethylene patch closures (PTFE), and 130 v

76 tissue regeneration barrier materials; i.e., polytetrafluoroethylene, polylactic acid, and sterile ca

77 Here, electrostatic charges on Teflon (polytetrafluoroethylene) produced by rubbing with Lucite

78 ortality study (1950-2008) that included all polytetrafluoroethylene production sites in Europe and N

79 lar yield was greatest with impressions from polytetrafluoroethylene (PTFE [Teflon]; BioPore; Millipo

80 In this study, we compared SIS to polytetrafluoroethylene (PTFE) as a vascular patch for a

81 reduced risk of CAUTI compared with standard polytetrafluoroethylene (PTFE) catheterisation.

82 t an absorption spectrometric method using a polytetrafluoroethylene (PTFE) cell as a diffuse reflect

83 chain length C(10), C(12) and C(14)) through polytetrafluoroethylene (PTFE) filters (0.45 microm pore

84 Failure of an arteriovenous polytetrafluoroethylene (PTFE) graft, the most common fo

85 ross 26 lesions at the venous anastomosis of polytetrafluoroethylene (PTFE) grafts in 25 patients (11

86 or arteriovenous fistulas (AVFs) and 23% for polytetrafluoroethylene (PTFE) grafts.

87 nduits made from cryopreserved homograft and polytetrafluoroethylene (PTFE) in 66 cases (54 pulmonary

88 possible to accurately predict the depth of Polytetrafluoroethylene (PTFE) layer purely on the basis

89 a carbon nanotubes (CNT) film deposited on a polytetrafluoroethylene (PTFE) membrane was assembled an

90 red with an acellular dermal matrix (ADM) or polytetrafluoroethylene (PTFE) membrane.

91 oduced into rats in a chamber created from a polytetrafluoroethylene (PTFE) ring placed under the ser

92 Experiments were conducted on polytetrafluoroethylene (PTFE) specimen and a reasonably

93 oly (N-isopropylacrylamide), (PNIPAM) within polytetrafluoroethylene (PTFE) to form a multi-dimension

94 1990, we have utilized a 2-mm thick sheet of polytetrafluoroethylene (PTFE) to overcome this situatio

95 liquid delivery system (PMLDS) coupled to a polytetrafluoroethylene (PTFE) total-consumption microne

96 cutaneous implantation of two small, sterile polytetrafluoroethylene (PTFE) tubes into the deltoid re

97 drophobic surfaces are composed of amorphous polytetrafluoroethylene (PTFE) with a static contact ang

98 ons with controlled numbers of balls made of polytetrafluoroethylene (PTFE), polymethylmethacrylate (

99 Finally, in tests on polytetrafluoroethylene (PTFE), we found that geckos clu

100 rformed by using a 10-mm or an 8-mm-diameter polytetrafluoroethylene (PTFE)-covered stent in a consec

101 years; range, 45-65 years) by using nitinol polytetrafluoroethylene (PTFE)-covered stent-grafts.

102 ibocharging events at metal-insulator [e.g., polytetrafluoroethylene (PTFE)] interfaces: injection of

103 Chordal replacement with polytetrafluoroethylene sutures is an accepted and repro

104 ical effects of tetracycline-coated expanded polytetrafluoroethylene (T-ePTFE) barrier membranes in t

105 nd negatively charged polymeric beads, e.g., polytetrafluoroethylene (Teflon) and polyamide-imide (To

106 ors have observed intermediate patency using polytetrafluoroethylene to a vein cuff and anticoagulati

107 on with nitric acid and hydrogen peroxide in polytetrafluoroethylene tubes.

108 Use of polytetrafluoroethylene vessels and intensive grinding o

109 Balloon-expandable stents covered with polytetrafluoroethylene were placed in 11 aortoiliac les

110 he following: polytetrafluorethylene (PTFE); polytetrafluoroethylene with an additional modifier, per